The most frequently reported baseline measures of participants in highly likely applicable clinical trials (HLACT)(N = 13,808) by units and dispersion.
†3×2 cm abscess beginning three days after second immunization; subject withdrawn from further doses of vaccine; abscess resolved spontaneously. ††Subject developed severe pain, swelling and erythema,